Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Cancers
|
May 14, 2025
Lung Cancer Risk Prediction in Patients with Persistent Pulmonary Nodules Using the Brock Model and Sybil Model
Hui Li, Morteza Salehjahromi, Myrna C B Godoy, et al.
Journal for Immunotherapy of Cancer
|
October 26, 2024
Ten challenges and opportunities in computational immuno-oncology
Riyue Bao, Alan Hutson, Anant Madabhushi, et al.
JTO Clinical and Research Reports
|
August 31, 2023
Brief Report: Clinical Response, Toxicity, and Resistance Mechanisms to Osimertinib Plus MET Inhibitors in Patients With EGFR-Mutant MET-Amplified NSCLC
Kaiwen Wang, Robyn Du, Sinchita Roy-Chowdhuri, et al.
JTO Clinical and Research Reports
|
January 13, 2025
Brief Report: Clinical Characteristics and Outcomes of Patients With Thoracic SMARCA4-Deficient Undifferentiated Tumors
Alissa J Cooper, Andrea Arfe, Biagio Ricciuti, et al.
Biorxiv : the Preprint Server for Biology
|
November 18, 2024
Stratified analysis identifies HIF-2<i>α</i> as a therapeutic target for highly immune-infiltrated melanomas
Amy Y Huang, Kelly P Burke, Ryan Porter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 24, 2025
Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC-A Real-World Case Series: Case Report
Bingnan Zhang, Komal B Shah, Mitchell Parma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2024
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities
C Allison Stewart, Lixia Diao, Yuanxin Xi, et al.
Cancers
|
November 13, 2025
Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients
Morteza Salehjahromi, Hui Li, Eman Showkatian, et al.
JCO Precision Oncology
|
April 23, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity
Mitchell Parma, Kaiwen Wang, Ceylan Altintas Taslicay, et al.
JTO Clinical and Research Reports
|
February 15, 2024
Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From <i>EGFR</i>-Mutant NSCLC Informs Potential Therapeutic Targets
Bingnan Zhang, Whitney Lewis, C Allison Stewart, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Cancers
|
May 14, 2025
Lung Cancer Risk Prediction in Patients with Persistent Pulmonary Nodules Using the Brock Model and Sybil Model
Hui Li, Morteza Salehjahromi, Myrna C B Godoy, et al.
Journal for Immunotherapy of Cancer
|
October 26, 2024
Ten challenges and opportunities in computational immuno-oncology
Riyue Bao, Alan Hutson, Anant Madabhushi, et al.
JTO Clinical and Research Reports
|
August 31, 2023
Brief Report: Clinical Response, Toxicity, and Resistance Mechanisms to Osimertinib Plus MET Inhibitors in Patients With EGFR-Mutant MET-Amplified NSCLC
Kaiwen Wang, Robyn Du, Sinchita Roy-Chowdhuri, et al.
JTO Clinical and Research Reports
|
January 13, 2025
Brief Report: Clinical Characteristics and Outcomes of Patients With Thoracic SMARCA4-Deficient Undifferentiated Tumors
Alissa J Cooper, Andrea Arfe, Biagio Ricciuti, et al.
Biorxiv : the Preprint Server for Biology
|
November 18, 2024
Stratified analysis identifies HIF-2<i>α</i> as a therapeutic target for highly immune-infiltrated melanomas
Amy Y Huang, Kelly P Burke, Ryan Porter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 24, 2025
Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC-A Real-World Case Series: Case Report
Bingnan Zhang, Komal B Shah, Mitchell Parma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2024
YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities
C Allison Stewart, Lixia Diao, Yuanxin Xi, et al.
Cancers
|
November 13, 2025
Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients
Morteza Salehjahromi, Hui Li, Eman Showkatian, et al.
JCO Precision Oncology
|
April 23, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity
Mitchell Parma, Kaiwen Wang, Ceylan Altintas Taslicay, et al.
JTO Clinical and Research Reports
|
February 15, 2024
Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From <i>EGFR</i>-Mutant NSCLC Informs Potential Therapeutic Targets
Bingnan Zhang, Whitney Lewis, C Allison Stewart, et al.
Page
of 4